Overview

A Study in Japanese Children With Short Bowel Syndrome Who Completed SHP633-302

Status:
Active, not recruiting
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this clinical study is to evaluate the long-term safety and tolerability of teduglutide treatment in Japanese pediatric participants with short bowel syndrome (SBS) who completed Study SHP633-302 (NCT02980666).
Phase:
Phase 3
Details
Lead Sponsor:
Shire
Collaborator:
Takeda
Treatments:
Teduglutide